Banner for leaf pages 2

Lacosamide (Vimpat)

Also known as Vimpat

Lacosamide (INN, formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat.

Source: Wikipedia

Estimated Total Cost: $378.79 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed lacosamide to treat epilepsy, seizures, rabies, and blastomycosis.

What side effects are related?

Patients taking lacosamide most commonly experience side effects like headache, nausea, and fatigue.

Ajax-loader Loading...